What is Ironwood Pharmaceuticals's D&A?

Ironwood Pharmaceuticals (IRWD) reported D&A of $443K in Q1 2026.

How has Ironwood Pharmaceuticals's D&A changed year-over-year?

Ironwood Pharmaceuticals's D&A decreased by 7.5% year-over-year, from $479K to $443K.

What is the long-term trend for Ironwood Pharmaceuticals's D&A?

Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's D&A has grown at a 5.4% compound annual growth rate (CAGR), from $1.52M to $1.88M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Ironwood Pharmaceuticals IRWD D&A

D&A at other companies

Bausch Health CompaniesBHC

$295M-3.3%

ArdelyxARDX

$915K+52.0%

Eton Pharmaceuticals, Inc.ETON

$1.13M+11.6%

Rigel PharmaceuticalsRIGL

$597K-1.2%

ANI PharmaceuticalsANIP

$20.92M-8.6%

Catalyst PharmaceuticalCPRX

$70K-39.1%

Other financials

Income statement

See full

Revenue$106.5M+159%

Operating income$72.6M+349%

Net income$40.8M+209%

EPS (diluted)$0.24+204%

Balance sheet

See full

Cash & equivalents$220.5M+103%

Total debt$212.4M+1,323%

Total equity-$217.1M+35.0%

Total assets$434.6M+32.8%

Cash flow

See full

Operating cash flow$5.1M-74.3%

CapEx-—

Free cash flow$74.6M+390%

Valuation

See full

Market cap$632.12M+457%

Enterprise value$624M+3,024%

P/E6.2×—

P/S1.8×+1.4×

Profitability

See full

Gross margin99.2%—

Operating margin55.4%+38.7pp

Net margin28.3%+22.3pp

FCF margin24.7%-11.1pp

Returns & leverage

See full

Return on equity29.7%-138pp

Debt / equity0×-0.5×

Current ratio1.4×-1.9×

Where this comes from

Reported directly by Ironwood Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ironwood Pharmaceuticals's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ironwood Pharmaceuticals's D&A?: Ironwood Pharmaceuticals (IRWD) reported D&A of $443K in Q1 2026.
How has Ironwood Pharmaceuticals's D&A changed year-over-year?: Ironwood Pharmaceuticals's D&A decreased by 7.5% year-over-year, from $479K to $443K.
What is the long-term trend for Ironwood Pharmaceuticals's D&A?: Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's D&A has grown at a 5.4% compound annual growth rate (CAGR), from $1.52M to $1.88M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.